SecurityUS58462QAM33 / Medical Solutions Holdings, Inc., 2nd Lien Term Loan - 7.5% 2029-11-01
InstitutionBlackrock Floating Rate Income Trust
Latest Disclosed Value $ 158,969
Blackrock Floating Rate Income Trust ownership in US58462QAM33 / Medical Solutions Holdings, Inc., 2nd Lien Term Loan

2025-08-26 - Blackrock Floating Rate Income Trust has filed a NPORT-P form disclosing ownership of Medical Solutions Holdings, Inc., 2nd Lien Term Loan (US:US58462QAM33) valued at $158,969 USD as of 2025-06-30. Blackrock Floating Rate Income Trust had filed a previous NPORT-P on 2025-05-28 disclosing shares of Medical Solutions Holdings, Inc., 2nd Lien Term Loan valued at of $188,500 USD. This represents a change in value of -15.96 percent during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Medical Solutions Holdings Inc 2021 2nd Lien Term Loan LON US58462QAM33 159 -15.96 0.0473
2025-05-28 2025-03-31 NP Medical Solutions Holdings Inc 2021 2nd Lien Term Loan LON US58462QAM33 188 0.00 0.0574
2025-02-25 2024-12-31 NP Medical Solutions Holdings Inc 2021 2nd Lien Term Loan LON US58462QAM33 188 -23.27 0.0589
2024-11-26 2024-09-30 NP Medical Solutions Holdings Inc 2021 2nd Lien Term Loan LON US58462QAM33 245 -3.92 0.0821
2024-08-26 2024-06-30 NP Medical Solutions Holdings Inc 2021 2nd Lien Term Loan LON US58462QAM33 256 -15.28 0.0885
2024-05-28 2024-03-31 NP Medical Solutions Holdings Inc 2021 2nd Lien Term Loan LON US58462QAM33 301 -4.75 0.1047
2024-02-26 2023-12-31 NP Medical Solutions Holdings Inc 2021 2nd Lien Term Loan LON US58462QAM33 316 -5.95 0.1099
2023-11-28 2023-09-30 NP Medical Solutions Holdings Inc 2021 2nd Lien Term Loan LON US58462QAM33 336 0.90 0.1175
2023-08-25 2023-06-30 NP Medical Solutions Holdings, Inc. 2021 2nd Lien Term Loan LON US58462QAM33 333 -2.35 0.1171
2023-05-26 2023-03-31 NP Medical Solutions Holdings, Inc. 2021 2nd Lien Term Loan LON US58462QAM33 341 -1.45 0.1211
2023-02-24 2022-12-31 NP Medical Solutions Holdings, Inc. 2021 2nd Lien Term Loan LON US58462QAM33 347 -3.35 0.1248
2022-11-25 2022-09-30 NP Medical Solutions Holdings, Inc. 2021 2nd Lien Term Loan LON US58462QAM33 358 3.47 0.1315
2022-08-25 2022-06-30 NP Medical Solutions Holdings, Inc. 2021 2nd Lien Term Loan LON US58462QAM33 347 -4.16 0.1281
2022-05-26 2022-03-31 NP Medical Solutions Holdings, Inc. 2021 2nd Lien Term Loan LON US58462QAM33 362 0.1221
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.